Literature DB >> 15264247

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.

Sara S Strom1, Yun Gu, Hui Zhang, Patricia Troncoso, Richard J Babaian, Curtis A Pettaway, Sanjay Shete, Margaret R Spitz, Christopher J Logothetis.   

Abstract

BACKGROUND: Little is known about the role of inherited genotypes in prostate cancer (PC) progression. This prospective study evaluated the predictive value of androgen receptor (AR) polymorphisms (CAG and GGC repeats) among prostatectomy patients.
METHODS: We studied 354 patients registered at M. D. Anderson Cancer Center from 1991 to 2001. Kaplan-Meier and Cox proportional hazard analyses were used.
RESULTS: During an average follow-up of 56 months, 66 (19%) post-prostatectomy patients experienced biochemical failure (BF). Patients with higher CAG repeats (CAG > or = 24) had significantly longer BF-free survival (BFFS) than those with fewer repeats (CAG < or = 23) (P = 0.04). Higher CAG repeats were significantly associated with lower BF risk among Whites and African Americans. Among Whites, longer CAG repeats (relative risk (RR) = 0.45, P = 0.03) and Gleason score > or = 8 (RR = 19.33, P = 0.005) remained significant BFFS predictors in multivariate analysis. GGC repeats were not associated with BF.
CONCLUSIONS: Our data showed that an inherited polymorphism (CAG repeats) in the AR is related to differences in genetic susceptibility to BF, supporting the hypothesis that increased AR activity may play a role in PC progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264247     DOI: 10.1002/pros.20060

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Dietary energy balance modulates prostate cancer progression in Hi-Myc mice.

Authors:  Jorge Blando; Tricia Moore; Stephen Hursting; Guiyu Jiang; Achinto Saha; Linda Beltran; Jianjun Shen; John Repass; Sara Strom; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-27

2.  Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer.

Authors:  Manish Kohli; Paul G Rothberg; Changyong Feng; Edward Messing; Jean Joseph; Sreevidya Sadasiva Rao; Allison Hendershot; Deepak Sahsrabudhe
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 3.  The role of BRCA1 and BRCA2 in prostate cancer.

Authors:  Elena Castro; Rosalind Eeles
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

4.  The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patients.

Authors:  Curtis A Pettaway; Renduo Song; Xuemei Wang; Ricardo Sanchez-Ortiz; Philippe E Spiess; Sara Strom; Patricia Troncoso
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

Review 5.  The genetic epidemiology of prostate cancer and its clinical implications.

Authors:  Rosalind Eeles; Chee Goh; Elena Castro; Elizabeth Bancroft; Michelle Guy; Ali Amin Al Olama; Douglas Easton; Zsofia Kote-Jarai
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

6.  Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.

Authors:  Christopher A Haiman; Gary K Chen; William J Blot; Sara S Strom; Sonja I Berndt; Rick A Kittles; Benjamin A Rybicki; William B Isaacs; Sue A Ingles; Janet L Stanford; W Ryan Diver; John S Witte; Stephen J Chanock; Suzanne Kolb; Lisa B Signorello; Yuko Yamamura; Christine Neslund-Dudas; Michael J Thun; Adam Murphy; Graham Casey; Xin Sheng; Peggy Wan; Loreall C Pooler; Kristine R Monroe; Kevin M Waters; Loic Le Marchand; Laurence N Kolonel; Daniel O Stram; Brian E Henderson
Journal:  PLoS Genet       Date:  2011-05-26       Impact factor: 5.917

Review 7.  Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.

Authors:  Mahbubl Ahmed; Rosalind Eeles
Journal:  Future Sci OA       Date:  2015-12-18

8.  A genome-wide association study of prostate cancer in Latinos.

Authors:  Zhaohui Du; Hannah Hopp; Sue A Ingles; Chad Huff; Xin Sheng; Brandi Weaver; Mariana Stern; Thomas J Hoffmann; Esther M John; Stephen K Van Den Eeden; Sara Strom; Robin J Leach; Ian M Thompson; John S Witte; David V Conti; Christopher A Haiman
Journal:  Int J Cancer       Date:  2019-07-03       Impact factor: 7.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.